AMEX · CPHI

China Pharma Holdings, Inc.

$1.13 -$0.39 (-25.66%) 1D Market open
Session Pulse Regular session 1 mentions on Wed No new SEC filings since Mon close its sector ranked 5/11 this week Full pulse →

Key Metrics

$61.59M
Market cap
P/E · TTM
$3.99M
Revenue · TTM
−$3.55M
Net income
EPS · TTM $-1.09
Dividend yield
Free cash flow $91.47K
Beta · 1Y 1.18
EBITDA · TTM −$2.22M
Gross margin 7.3%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 27
    From its Jul 21 high, the share price fell 85%.

    Peak close $8.10 on Jul 21; trough close $1.23 on Jul 27. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -85%
  • Jul 23
    Offering paper hit the record (Form 424B5).

    424B5 - CHINA PHARMA HOLDINGS, INC. (0001106644) (Filer)

    RECEIPT: SEC FORM 424B5, TIMESTAMPED
  • Jul 22
    A material event was filed (Form 8-K).

    8-K - CHINA PHARMA HOLDINGS, INC. (0001106644) (Filer)

    RECEIPT: SEC FORM 8-K, TIMESTAMPED
  • Jul 21
    The stock moved +790.1% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jul 21
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jul 15
    The stock moved +78.9% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jul 15

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$61.59M
Enterprise value
Shares outstanding40.5M
52-wk range$0.38 – $19.19
Avg volume · 20D220.1K
Net cash
Book value / share$11.35
IndustryPharmaceutical Preparations
ExchangeAMEX
About China Pharma Holdings, Inc.
IPO dateApr 14, 2002
Employees221

China Pharma Holding Inc is a drug manufacturing company.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S15.43
P/FCF673.40
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross 7.3%
Operating -88.8%
Net -88.8%
FCF 2.3%
ROE / ROIC -15.8% · —

Financial Health

Current ratio0.28
Quick ratio0.07
Debt / equity
Debt / EBITDA
Net cash
Working capital−$5.26M

Cash Flow · TTM

Operating CF $150.79K
Capex −$59.32K
Free cash flow $91.47K
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

4 / 9
Middling fundamentals · 4 of 9 signals passing

Altman Z-Score

2.7
Grey zone (1.81–2.99) · monitor

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings